Organogenesis Holdings Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
ORGO on Nasdaq
Industry
Pharmaceutical Preparations
Location
85 Dan Road, Canton, MA

Insiders trading volume in the past year

Organogenesis Holdings Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dennis Erani 10%+ Owner $509M Dec 15, 2021
Dennis Erani 2012 Issue Trust dated 12/20/12 10%+ Owner $509M Dec 15, 2021
RED Holdings, LLC 10%+ Owner $509M Dec 28, 2021
Albert Erani Family Trust dated 12/29/2012 10%+ Owner $509M Dec 28, 2021
Alan A. Ades Director, 10%+ Owner $256M May 27, 2021
GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 10%+ Owner $254M Nov 18, 2021
Glenn H. Nussdorf Director, 10%+ Owner $254M Nov 18, 2021
Erani Albert 10%+ Owner $252M -$1.88M -0.74% Jan 9, 2024
Avista Capital Managing Member IV, LLC Director, 10%+ Owner $33M May 14, 2021
Gary S. Gillheeney President and CEO, Director $6.59M Apr 1, 2024
Patrick Bilbo Chief Operating Officer $2.27M Apr 1, 2024
David Francisco Chief Financial Officer $1.49M Feb 21, 2024
Brian Grow Chief Commercial Officer $1.46M Apr 1, 2024
Lori Freedman Chief Admin. and Legal Officer $1.31M Apr 1, 2024
Arthur S. Leibowitz Director $653K Feb 21, 2024
Prathyusha Duraibabu Director $517K Feb 21, 2024
Jon L. Giacomin Director $496K Feb 21, 2024
Michael Joseph Driscoll Director $495K Feb 21, 2024
Gilberto Quintero Director $490K Feb 21, 2024
Michele Ilene Korfin Director $490K Feb 21, 2024
Antonio S. Montecalvo Vice President, Health Policy $471K Apr 1, 2024
Robert Cavorsi Vice President, Strategy $432K Jul 16, 2024
Michael W. Katz 10%+ Owner $327K Nov 18, 2022
Starr Wisdom 10%+ Owner $85.6K Oct 15, 2020

Recent Insider Transactions by Companies or Individuals for Organogenesis Holdings Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.